 |
|
The following text is from an archived Red Book® edition and may not reflect current recommendations or information. To view the current edition, click here.
Section 1. Active and Passive Immunization
ACTIVE IMMUNIZATION
Vaccine Safety and Contraindications
RISKS AND ADVERSE EVENTSINSTITUTE OF MEDICINE IMMUNIZATION SAFETY REVIEW COMMITTEE
THE BRIGHTON COLLABORATION
REPORTING OF ADVERSE EVENTS
CLINICAL IMMUNIZATION SAFETY ASSESSMENT NETWORK
VACCINE SAFETY DATALINK PROJECT
VACCINE IDENTIFICATION STANDARDS INITIATIVE
VACCINE INJURY COMPENSATION
PRECAUTIONS AND CONTRAINDICATIONS
HYPERSENSITIVITY REACTIONS TO VACCINE CONSTITUENTS
MISCONCEPTIONS ABOUT VACCINE CONTRAINDICATIONS
 Top Next |
|---|
RISKS AND ADVERSE EVENTS
All licensed vaccines in the United States are safe and effective, but no vaccine is completely safe and effective in every person. Some vaccine recipients will have an adverse reaction, and some will not always be fully protected. The goal of vaccine development is to achieve the highest degree of protection with the lowest rate of adverse events.
Risks of immunization may vary from trivial and inconvenient to severe and life threatening. When developing immunization recommendations, vaccine benefits and safety are weighed against the risks of natural disease to the person and the community. Many families lack awareness of the continued threat of certain vaccine-preventable diseases (eg, pertussis and measles) in their community and the risk of tetanus among unimmunized people. Recommendations attempt to maximize protection and minimize risk by providing specific advice on dose, route, and timing of the vaccine and by delineating people who should be immunized and circumstances that warrant precaution or contraindicate immunization.
Common vaccine adverse events usually are mild to moderate in severity (eg, fever or local swelling, redness, and pain at the injection site) and without permanent sequelae. Because such reactions are intrinsic to the immunizing antigen or some other component of the vaccine, they occur frequently and are unavoidable. Examples include local inflammation after administration of DTaP vaccine and fever and rash 1 to 2 weeks after administration of MMR vaccine.
Sterile abscesses have occurred at the site of
Related text in Red Book:
- Summary of Major Changes in the 2003 Red Book
Red Book 2003: xxv.[Extract] [Full Version] - Immunizing Antigens
Red Book 2003: 9-10.[Extract] [Full Version] - Record Keeping and Immunization Registries
Red Book 2003: 36-37.[Extract] [Full Version] - Parental Misconceptions About Immunizations
Red Book 2003: 50-53.[Extract] [Full Version] - Vaccine Administration
Red Book 2003: 17-20.[Extract] [Full Version] - Immune Globulin
Red Book 2003: 54-56.[Extract] [Full Version] - Treatment of Anaphylactic Reactions
Red Book 2003: 63-66.[Extract] [Full Version] - Preterm and Low Birth Weight Infants
Red Book 2003: 66-68.[Extract] [Full Version] - Immunocompromised Children
Red Book 2003: 69-81.[Extract] [Full Version] - Children With a Personal or Family History of Seizures
Red Book 2003: 81-82.[Extract] [Full Version] - Poliovirus Infections
Red Book 2003: 505-509.[Extract] [Full Version] - Rabies
Red Book 2003: 514-521.[Extract] [Full Version] - Rubella
Red Book 2003: 536-541.[Extract] [Full Version] - Tetanus (Lockjaw)
Red Book 2003: 611-616.[Extract] [Full Version] - Tuberculosis
Red Book 2003: 642-660.[Extract] [Full Version] - Varicella-Zoster Infections
Red Book 2003: 672-686.[Extract] [Full Version] - Hepatitis B
Red Book 2003: 318-336.[Extract] [Full Version] - Arboviruses (Including California Encephalitis [Primarily La Crosse], Eastern and Western Equine Encephalitis, Powassan Encephalitis, St Louis Encephalitis, Venezuelan Equine Encephalitis, West Nile Encephalitis, Colorado Tick Fever, Dengue, Japanese Encephalitis, and Yellow Fever)
Red Book 2003: 199-205.[Extract] [Full Version] - Influenza
Red Book 2003: 382-391.[Extract] [Full Version] - Measles
Red Book 2003: 419-429.[Extract] [Full Version] - Mumps
Red Book 2003: 439-443.[Extract] [Full Version] - Pertussis
Red Book 2003: 472-486.[Extract] [Full Version] - MedWatch—The FDA Safety Information and Adverse Event Reporting Program
Red Book 2003: 771-772.[Extract] [Full Version] - Directory of Resources
Red Book 2003: 789-794.[Extract] [Full Version] - Standards for Child and Adolescent Immunization Practices
Red Book 2003: 795-797.[Extract] [Full Version] - Guide to Contraindications and Precautions to Immunizations, 2003
Red Book 2003: 798-801.[Extract] [Full Version] - National Childhood Vaccine Injury Act. Reporting and Compensation Table.
Red Book 2003: 802-808.[Extract] [Full Version] - 2003 Red Book Erratum, P. 796
Red Book 2003: E7.[Extract] [Full Version]
| Advertisement |
|
|